Health and Environmental Science Institute (HESI), THRIVE, a partner in the 2018 Biden Cancer Initiative, provides seed grants for nonclinical, clinical, and translational research and technology-based solutions that enhance our ability to predict when and how adverse effects may occur in patients who have received cancer treatmentClick here for more information

Rheumatic Diseases Research Resource-based Center (RDRRC), Pilot and Feasibility Studies, Deadline for Pre-Proposals: April 6, 2019 – The Rheumatic Diseases Research Resource-based Center (RDRRC) at Washington University is pleased to announce the availability of research funds for its Pilot and Feasibility (P/F) programClick here for more information

Specialized Programs of Research Excellence (SPORE) in Pancreatic Cancer – Request for Applications, Deadline – April 30, 2019, 4 p.m. – Requests for applications are open to investigators affiliated with Washington University, Siteman Cancer Center, University of Rochester, University of North Carolina at Chapel Hill (Lineberger Comprehensive Cancer Center), and Johns Hopkins Medicine (The Sidney Kimmel Comprehensive Cancer Center)Click here for more information